ScinoPharm Taiwan, Ltd.
ScinoPharm Taiwan, Ltd. (TAI: 1789) is trading at NT$18.95, about ₹57 at today's TWD/INR rate, as of 30 Sep 2026, 1:30 AM ET, up 2.16% today. ScinoPharm Taiwan is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$18.65
Today's high
NT$19.10
52 week low
NT$16.70
52 week high
NT$29.10
1789 opened at NT$18.70, closed previously at NT$18.55, and has traded between NT$16.70 and NT$29.10 over the past 52 weeks.
About
ScinoPharm Taiwan, Ltd., along with its subsidiaries, specializes in the research, development, production, and global distribution of cGMP-compliant active pharmaceutical ingredients (APIs). The company supplies these APIs to pharmaceutical clients throughout Taiwan, the United States, Europe, India, various parts of Asia, and other international regions. Its service offerings include custom synthesis for biochemical molecules like peptides and nucleic acids, manufacturing of generic APIs, and comprehensive outsourcing solutions. ScinoPharm also provides Contract Research and Manufacturing (CRAM) services, which involve chemistry expertise, analytical and regulatory support, chemical process development, clinical drug substance manufacturing, and consulting. These CRAM services facilitate the creation and production of APIs and intermediates for clinical, small-scale, and commercial applications. Moreover, the company actively develops advanced peptide synthesis technologies. ScinoPharm is involved in the development and manufacturing of a diverse range of products, such as Western medicines, various chemical materials, albumin-based drugs, oligonucleotide medicines, injectables, and novel small molecule drugs, alongside offering biotechnology and technical services. The company holds a strategic alliance with Baxter International Inc. focused on the joint development, production, and commercialization of an antiemetic drug for cancer chemotherapy. ScinoPharm Taiwan, Ltd. was founded in 1997 and has its headquarters in Tainan City, Taiwan.
Key statistics
Avg. volume
704.86K
Market cap
NT$14.98B
P/E Ratio
398.11
Price-to-sales ratio
4.88
Enterprise value
NT$11.15B
Free cash flow yield
2.27%
Debt-to-equity ratio
0.08
Return on equity
1.30%
ROIC
0.90%
Beta
0.43
Dividend yield
1.53%
Last dividend
NT$0.29
Financial overview
Revenue
NT$3.16B
Earnings per share
NT$0.17
Free cash flow
NT$305.82M
Net profit margin
1.23%
Gross margin
28.60%
EBITDA
NT$673.97M
Revenue growth
-7.13%
Similar securities
This is not an investment recommendation
ScinoPharm Taiwan for Indian investors
ScinoPharm Taiwan is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on ScinoPharm Taiwan for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. ScinoPharm Taiwan’s current yield is 1.53%.Dividend tax explained
FAQs
Can I buy ScinoPharm Taiwan on Paasa?
ScinoPharm Taiwan (1789) has been listed on the Taiwan Stock Exchange since 2011, in the Drug Manufacturers - Specialty & Generic industry. ScinoPharm Taiwan is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one ScinoPharm Taiwan share cost in rupees?
One ScinoPharm Taiwan share is NT$18.95 — about ₹57 at a TWD/INR rate of 3.02 on 29 Sep 2026. Both the ScinoPharm Taiwan price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on ScinoPharm Taiwan shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the ScinoPharm Taiwan price.
Does ScinoPharm Taiwan pay a dividend, and how is it taxed in India?
Yes. ScinoPharm Taiwan pays a dividend and the current yield is 1.53%; the last declared dividend was NT$0.29 per share, about ₹0.87. Dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Do I have to declare ScinoPharm Taiwan shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on ScinoPharm Taiwan?
Yes. ScinoPharm Taiwan is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.